Search Result "everolimus"


mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 945-954
Author(s): A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta, G. Ranieri

Research Article

Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease

Journal: Current Vascular Pharmacology
Volume: 15 Issue: 3 Year: 2017 Page: 257-264
Author(s): Arturo Giordano,Paolo Ferraro,Nicola Corcione,Stefano Messina,Gennaro Maresca,Enrico Coscioni,Raffaella Avellino,Gabriele Giordano,Mariangela Peruzzi,Antonino G. M. Marullo,Giovanni Napolitano,Maria Fiammetta Romano,Giuseppe Biondi-Zoccai

Clinical Studies with Sirolimus, Zotarolimus, Everolimus and Biolimus A9 Drug- Eluting Stent Systems

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 4012-4024
Author(s): Bimmer E. Claessen, Jose P.S. Henriques, George D. Dangas

Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 121-125
Author(s): Zhaode Bu, Jiafu Ji

Platelet Reactivity in Patients with Coronary Stenting Treated with Dual Antiplatelet Therapy and after Withdrawal of Clopidogrel: Impact of Bioactive Titanium Stent versus Everolimus-coated Stent

Ebook: Recent Advances in Alzheimer Research

Volume: 4 Year: 2019
Author(s): Amparo Hernandiz,Jose Luis Díez,Antonio Moscardo,Ana Latorre,Maria Dolores Domenech,Maria Teresa Santos,Juana Valles
Doi: 10.2174/97816810839951180401

Targeting mTOR Pathways in Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2766-2777
Author(s): Angelica Fasolo,Cristiana Sessa

Research Article

High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 18 Issue: 0 Year: 2021 Page: 1-16
Author(s): Simona Granata,Alberto Verlato,Valentina Masola,Amedeo Carraro,Gloria Santoro,Fabio Sallustio,Gianluigi Zaza

Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma

Journal: Current Clinical Pharmacology
Volume: 6 Issue: 3 Year: 2011 Page: 214-221
Author(s): Holleh D. Husseinzadeh, Jorge A. Garcia

Research Article

False Immunosuppressant Measurement by LC-MS/MS Method Due to Radiopaque Agents

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 2 Year: 2019 Page: 129-134
Author(s): Ataman Gönel,Ismail Koyuncu

Previous   Next

Go To   Results 1 - 1 of 729

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy